RSLS 13D/13G Filings - ReShape Lifesciences Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2021-03-15 10:50 am Unchanged	2021-03-12	13D	ReShape Lifesciences Inc. RSLS	DOMAIN PARTERS VII L P	5 9.800%	0 (Unchanged)	Filing History
2021-02-16 5:07 pm Unchanged	2020-12-31	13G	ReShape Lifesciences Inc. RSLS	ARMISTICE CAPITAL LLC	5 14.200%	0 (Unchanged)	Filing History
2021-02-12 3:32 pm Sale	2020-12-31	13G	ReShape Lifesciences Inc. RSLS	MORGAN STANLEY MS	0 0.000%	-2 (-99.97%)	Filing History
2021-02-12 06:09 am Unchanged	2010-02-28	13G	ReShape Lifesciences Inc. RSLS	INTERWEST PARTNERS X LP	2 5.100%	0 (Unchanged)	Filing History
2021-01-08 09:49 am Sale	2020-12-31	13G	ReShape Lifesciences Inc. RSLS	SABBY MANAGEMENT LLC	2 11.000%	-1 (-32.02%)	Filing History
2020-11-10 5:14 pm Purchase	2020-10-31	13G	ReShape Lifesciences Inc. RSLS	ARMISTICE CAPITAL LLC	5 14.200%	2 (+57.21%)	Filing History
2020-10-23 4:30 pm Unchanged	2020-10-23	13D	ReShape Lifesciences Inc. RSLS	DOMAIN PARTERS VII L P	5 12.600%	0 (Unchanged)	Filing History
2020-09-25 4:33 pm Purchase	2020-09-17	13G	ReShape Lifesciences Inc. RSLS	ARMISTICE CAPITAL LLC	3 9.000%	3 (New Position)	Filing History
2020-08-31 4:26 pm Purchase	2020-08-24	13G	ReShape Lifesciences Inc. RSLS	MORGAN STANLEY MS	2 5.900%	2 (New Position)	Filing History

Goto Prev, 0, 1